Balchem Corp Files 8-K: Regulation FD & Financials
Ticker: BCPC · Form: 8-K · Filed: Dec 10, 2025 · CIK: 9326
| Field | Detail |
|---|---|
| Company | Balchem CORP (BCPC) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, financial-statements, disclosure
Related Tickers: BCPC
TL;DR
Balchem filed an 8-K on Dec 10, 2025, covering Dec 9 events. Financials and Reg FD updates.
AI Summary
Balchem Corporation filed an 8-K on December 10, 2025, reporting events that occurred on December 9, 2025. The filing is related to Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Maryland and headquartered in Montvale, NJ.
Why It Matters
This 8-K filing indicates Balchem Corporation is disclosing important information regarding financial statements and compliance with Regulation FD, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and regulatory compliance, not indicating any immediate operational or financial distress.
Key Players & Entities
- BALCHEM CORP (company) — Registrant
- December 9, 2025 (date) — Earliest event reported
- December 10, 2025 (date) — Date of report
- Maryland (jurisdiction) — State of incorporation
- Montvale, NJ (location) — Principal executive offices
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The filing indicates 'Financial Statements and Exhibits' are included, but the specific details of these documents are not provided in the provided text.
What is the significance of the 'Regulation FD Disclosure' item?
This indicates that Balchem Corporation is making public disclosures to prevent selective disclosure of material non-public information, ensuring all investors receive information simultaneously.
When was Balchem Corporation incorporated?
Balchem Corporation was incorporated in Maryland.
What is the primary business address of Balchem Corporation?
The primary business address is 5 Paragon Drive, Montvale, NJ 07645.
What is the IRS Employer Identification Number for Balchem Corporation?
The IRS Employer Identification Number for Balchem Corporation is 13-2578432.
Filing Stats: 546 words · 2 min read · ~2 pages · Grade level 13.5 · Accepted 2025-12-10 16:15:55
Filing Documents
- ef20061036_8k.htm (8-K) — 29KB
- ef20061036_ex99-1.htm (EX-99.1) — 7KB
- image00002.jpg (GRAPHIC) — 9KB
- image00006.jpg (GRAPHIC) — 4KB
- 0001140361-25-045137.txt ( ) — 181KB
- bcpc-20251209.xsd (EX-101.SCH) — 4KB
- bcpc-20251209_lab.xml (EX-101.LAB) — 21KB
- bcpc-20251209_pre.xml (EX-101.PRE) — 16KB
- ef20061036_8k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On December 10, 2025, Balchem Corporation (the "Company") issued a press release announcing a dividend declared by the Company's Board of Directors on December 9, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. Further, on December 9, 2025, the Board of Directors of the Company approved a new stock repurchase program which replaces the previous program that was in place and authorizes the repurchase of up to, and including, 4 million shares of the Company's ordinary shares. This new stock repurchase program has no expiration date, does not oblige the Company to acquire any particular amount of the Company's ordinary shares, and may be terminated at any time. Share repurchases may be made from time to time in the open market, including pursuant to a share repurchase agreement in compliance with Rule 10b-18 or a trading plan established pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and in privately negotiated transactions at the discretion of management.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 104 Press Release dated December 10, 2025 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BALCHEM CORPORATION (Registrant) By: /s/ Hatsuki Miyata Hatsuki Miyata Executive Vice President, Chief Legal Officer and Secretary Date: December 10, 2025